In contrast, Akhtari et al. found no significant differences in the frequency of activating KIR genes between SLE patients and controls in an Iranian population However, they highlighted interactions between specific KIR and HLA alleles influencing clinical manifestations of SLE, such as hematological and renal disorders [117]. This evidence concerns the gene KIR3DL1 and systemic lupus erythematosus.